Intrathecal dexamethasone therapy for febrile infection-related epilepsy syndrome.
Asako HorinoIchiro KukiTakeshi InoueMegumi NukuiShin OkazakiHisashi KawawakiMasao TogawaKiyoko AmoJunichi IshikawaAtsushi UjiroMasashi ShiomiHiroshi SakumaPublished in: Annals of clinical and translational neurology (2021)
IT-DEX represents a therapeutic option for patients with FIRES that could shorten the duration of the critical stage of the disease. The effect of IT-DEX on FIRES might include cytokine-independent mechanisms.